Safety of SNK01 in Subjects With Mild Cognitive Impairment (MCI) and Alzheimer's Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Alzheimer Disease
- Mild Cognitive Impairment
- Neuro-Degenerative Disease
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 55 years and 85 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04678453
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Clemente Humberto Zúñiga Gil, MD Hospital Angeles Tijuana
Get Well Soon